Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohort.

Journal

Cancer immunology, immunotherapy : CII
ISSN: 1432-0851
Titre abrégé: Cancer Immunol Immunother
Pays: Germany
ID NLM: 8605732

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 30 4 2020
medline: 30 4 2020
entrez: 30 4 2020
Statut: ppublish

Résumé

The original version of this article unfortunately contained a mistake. The second sentence of the section "irAEs and ICI efficacy" should read as.

Identifiants

DOI: 10.1007/s00262-020-02582-z PMID: 32347358
pubmed: 32347358
doi: 10.1007/s00262-020-02582-z
pii: 10.1007/s00262-020-02582-z
doi:

Types de publication

Journal Article Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

1189

Commentaires et corrections

Type : ErratumFor

Auteurs

Abdul Rafeh Naqash (AR)

Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Clinic, National Cancer Institute, Bldg 31/3A44, 31 Centre Drive, Bethesda, MD, 20892, USA. abdulrafeh.naqash@nih.gov.
Division of Hematology/Oncology, Department of Internal Medicine, East Carolina University, Greenville, NC, USA. abdulrafeh.naqash@nih.gov.

Biagio Ricciuti (B)

Thoracic Oncology Unit, Santa Maria Della Misericordia Hospital, University of Perugia, Perugia, Italy.
Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Dwight H Owen (DH)

Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA.

Vaia Florou (V)

Division of Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Division of Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.

Yukihiro Toi (Y)

Department of Pulmonary Medicine, Sendai Kousei Hospital, Hirosemachi, Aoba-Ku, Sendai, Japan.

Cynthia Cherry (C)

Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Clinic, National Cancer Institute, Bldg 31/3A44, 31 Centre Drive, Bethesda, MD, 20892, USA.
Division of Hematology/Oncology, Department of Internal Medicine, East Carolina University, Greenville, NC, USA.

Maida Hafiz (M)

Department of Pulmonary Medicine, East Carolina University, Greenville, NC, USA.

Andrea De Giglio (A)

Thoracic Oncology Unit, Santa Maria Della Misericordia Hospital, University of Perugia, Perugia, Italy.

Mavish Muzaffar (M)

Division of Hematology/Oncology, Department of Internal Medicine, East Carolina University, Greenville, NC, USA.

Sandip H Patel (SH)

Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA.

Shunichi Sugawara (S)

Department of Pulmonary Medicine, Sendai Kousei Hospital, Hirosemachi, Aoba-Ku, Sendai, Japan.

Jarred Burkart (J)

Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA.

Wungki Park (W)

Division of Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Memorial Sloan Kettering Cancer Center, New York, USA.

Rita Chiari (R)

Thoracic Oncology Unit, Santa Maria Della Misericordia Hospital, University of Perugia, Perugia, Italy.

Jun Sugisaka (J)

Department of Pulmonary Medicine, Sendai Kousei Hospital, Hirosemachi, Aoba-Ku, Sendai, Japan.

Gregory A Otterson (GA)

Division of Medical Oncology, Department of Internal Medicine, Ohio State University, Columbus, OH, USA.

Gilberto de Lima Lopes (G)

Division of Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.

Paul R Walker (PR)

Division of Hematology/Oncology, Department of Internal Medicine, East Carolina University, Greenville, NC, USA.

Classifications MeSH